Alkem Laboratories Limited (ALKEM.BO)
INR 4835.45
(2.88%)
INR 4835.45
(2.88%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 32.83 Billion INR | -39.12% |
| 2022 | 53.93 Billion INR | 20.51% |
| 2021 | 44.75 Billion INR | 28.96% |
| 2020 | 34.7 Billion INR | 0.15% |
| 2019 | 34.65 Billion INR | 6.99% |
| 2018 | 32.39 Billion INR | 15.8% |
| 2017 | 27.97 Billion INR | 17.63% |
| 2016 | 23.78 Billion INR | 11.17% |
| 2015 | 21.39 Billion INR | 34.82% |
| 2014 | 15.86 Billion INR | 36.83% |
| 2013 | 11.59 Billion INR | 21.78% |
| 2012 | 9.52 Billion INR | 20.85% |
| 2011 | 7.87 Billion INR | 23.79% |
| 2010 | 6.36 Billion INR | 17.96% |
| 2009 | 5.39 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.44 Billion INR | -19.08% |
| 2023 Q1 | 14.52 Billion INR | 5.85% |
| 2023 FY | 32.83 Billion INR | -39.12% |
| 2023 Q3 | 13.81 Billion INR | -4.09% |
| 2023 Q4 | 9.2 Billion INR | -33.35% |
| 2023 Q2 | 14.4 Billion INR | -0.83% |
| 2022 Q2 | 13.95 Billion INR | 3.1% |
| 2022 Q4 | 13.72 Billion INR | 7.93% |
| 2022 FY | 53.93 Billion INR | 20.51% |
| 2022 Q1 | 13.53 Billion INR | 39.72% |
| 2022 Q3 | 12.71 Billion INR | -8.92% |
| 2021 FY | 44.75 Billion INR | 28.96% |
| 2021 Q4 | 9.69 Billion INR | -19.33% |
| 2021 Q3 | 12.01 Billion INR | 0.87% |
| 2021 Q1 | 11.14 Billion INR | 39.54% |
| 2021 Q2 | 11.9 Billion INR | 6.89% |
| 2020 Q3 | 9.7 Billion INR | 7.97% |
| 2020 Q2 | 8.98 Billion INR | 11.87% |
| 2020 Q1 | 8.03 Billion INR | 29.68% |
| 2020 FY | 34.7 Billion INR | 0.15% |
| 2020 Q4 | 7.98 Billion INR | -17.7% |
| 2019 FY | 34.65 Billion INR | 6.99% |
| 2019 Q3 | 9.53 Billion INR | -1.03% |
| 2019 Q2 | 9.63 Billion INR | 3.72% |
| 2019 Q1 | 9.29 Billion INR | 26.73% |
| 2019 Q4 | 6.19 Billion INR | -35.05% |
| 2018 FY | 32.39 Billion INR | 15.8% |
| 2018 Q4 | 7.33 Billion INR | -12.51% |
| 2018 Q3 | 8.37 Billion INR | 0.17% |
| 2018 Q2 | 8.36 Billion INR | 0.6% |
| 2018 Q1 | 8.31 Billion INR | 0.95% |
| 2017 Q4 | 8.23 Billion INR | 4.04% |
| 2017 FY | 27.97 Billion INR | 17.63% |
| 2017 Q1 | 6.69 Billion INR | 0.21% |
| 2017 Q2 | 7.3 Billion INR | 9.24% |
| 2017 Q3 | 7.91 Billion INR | 8.32% |
| 2016 FY | 23.78 Billion INR | 11.17% |
| 2016 Q3 | 6.79 Billion INR | -1.26% |
| 2016 Q4 | 6.67 Billion INR | -1.8% |
| 2016 Q1 | 6.12 Billion INR | 4.45% |
| 2016 Q2 | 6.88 Billion INR | 12.46% |
| 2015 Q1 | 5.35 Billion INR | 52.17% |
| 2015 Q2 | 5.83 Billion INR | 8.78% |
| 2015 FY | 21.39 Billion INR | 34.82% |
| 2015 Q4 | 5.86 Billion INR | 11.42% |
| 2015 Q3 | 5.26 Billion INR | -9.76% |
| 2014 Q1 | 3.73 Billion INR | 0.0% |
| 2014 FY | 15.86 Billion INR | 36.83% |
| 2014 Q4 | 3.52 Billion INR | -13.45% |
| 2014 Q2 | 3.73 Billion INR | 0.0% |
| 2014 Q3 | 4.06 Billion INR | 9.06% |
| 2013 FY | 11.59 Billion INR | 21.78% |
| 2012 FY | 9.52 Billion INR | 20.85% |
| 2011 FY | 7.87 Billion INR | 23.79% |
| 2010 FY | 6.36 Billion INR | 17.96% |
| 2009 FY | 5.39 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -106.904% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 16.312% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -182.071% |
| Granules India Limited | 7.18 Billion INR | -357.161% |
| Indoco Remedies Limited | 4.74 Billion INR | -591.442% |
| Achyut Healthcare Limited | 1.6 Million INR | -2040608.515% |
| Ajanta Pharma Limited | 30.46 Billion INR | -7.788% |
| Alpa Laboratories Limited | 156.14 Million INR | -20928.262% |
| Brooks Laboratories Limited | 51.18 Million INR | -64055.92% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -1162.69% |
| Bajaj HealthCare Limited | 985.34 Million INR | -3232.335% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -2213.592% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 65.753% |
| Eris Lifesciences Limited | 4.94 Billion INR | -564.281% |
| FDC Limited | 5.34 Billion INR | -513.907% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 51.402% |
| Gufic Biosciences Limited | 1.07 Billion INR | -2946.735% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -1445.77% |
| Ipca Laboratories Limited | 13.91 Billion INR | -135.97% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -4145.484% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -71039.18% |
| Lasa Supergenerics Limited | 291.17 Million INR | -11176.762% |
| Laurus Labs Limited | 3.01 Billion INR | -990.574% |
| Lupin Limited | 95.67 Billion INR | 65.68% |
| Mankind Pharma Limited | 23.15 Billion INR | -41.819% |
| Medicamen Biotech Limited | 335.16 Million INR | -9696.609% |
| Medico Remedies Limited | 161.84 Million INR | -20188.055% |
| Megasoft Limited | 49.52 Million INR | -66195.834% |
| NATCO Pharma Limited | 10.05 Billion INR | -226.457% |
| Piramal Pharma Limited | 19.91 Billion INR | -64.884% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1907.643% |
| Sigachi Industries Limited | 579.88 Million INR | -5562.31% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 78.704% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -2240.694% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -3384.193% |
| Unichem Laboratories Limited | 6.72 Billion INR | -388.19% |
| Wanbury Limited | 1.16 Billion INR | -2728.343% |
| Windlas Biotech Limited | 1 Billion INR | -3162.263% |
| ZIM Laboratories Limited | 1.01 Billion INR | -3141.177% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 23.947% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -967.18% |
| Divi's Laboratories Limited | 14.17 Billion INR | -131.722% |
| Hester Biosciences Limited | 908.84 Million INR | -3512.847% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -996.181% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -2887.749% |
| Bal Pharma Limited | 389.89 Million INR | -8321.606% |
| Strides Pharma Science Limited | 9.16 Billion INR | -258.371% |
| Venus Remedies Limited | 1.91 Billion INR | -1613.473% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -968.013% |
| Nectar Lifesciences Limited | 625.55 Million INR | -5148.981% |
| Shilpa Medicare Limited | 2.18 Billion INR | -1405.786% |
| Aarti Drugs Limited | 1.16 Billion INR | -2712.47% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -2888.26% |
| Suven Life Sciences Limited | 109.75 Million INR | -29817.995% |
| Ind-Swift Limited | 946.56 Million INR | -3368.851% |
| Valiant Laboratories Limited | 36.28 Million INR | -90381.964% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -290.1% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -616.968% |
| Themis Medicare Limited | 782.85 Million INR | -4094.263% |
| Hikal Limited | 2.48 Billion INR | -1220.616% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -53.276% |
| Sequent Scientific Limited | 2.9 Billion INR | -1031.535% |
| Novartis India Limited | 470.1 Million INR | -6884.684% |
| Wockhardt Limited | 6.4 Billion INR | -413.047% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -127.169% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -202463.909% |
| Neuland Laboratories Limited | 2.92 Billion INR | -1020.746% |
| Morepen Laboratories Limited | 1.98 Billion INR | -1552.117% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -7861.409% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -4756.193% |